tyrosyl-arginyl-phenylalanyl-sarcosine has been researched along with rimorphin in 1 studies
| Studies (tyrosyl-arginyl-phenylalanyl-sarcosine) | Trials (tyrosyl-arginyl-phenylalanyl-sarcosine) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-sarcosine) | Studies (rimorphin) | Trials (rimorphin) | Recent Studies (post-2010) (rimorphin) |
|---|---|---|---|---|---|
| 15 | 0 | 1 | 188 | 2 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, T; Ito, K; Katsuyama, S; Mizoguchi, H; Sakurada, S; Sakurada, T; Watanabe, C; Watanabe, H | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-sarcosine and rimorphin
| Article | Year |
|---|---|
Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
Topics: Analgesics, Opioid; Animals; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; Mice, Inbred C57BL; Narcotic Antagonists; Nociceptors; Oligopeptides; Receptors, Opioid, mu; Spinal Cord | 2006 |